Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 14, 2006; 12(34): 5544-5549
Published online Sep 14, 2006. doi: 10.3748/wjg.v12.i34.5544
Table 1 Endoscopic findings
Endoscopic findingsn%
Nodular gastritis1642.1
Normal1334.2
Duodenal ulcer or erosive bulbitis410.5
Erosive duodenitis and nodular gastritis12.6
Erosive gastritis12.6
Nodular gastritis and esophagitis12.6
Duodenal ulcer and esophagitis12.6
Erosive duodenitis, esophagitis and nodular gastritis12.6
Table 2 Adverse effects reported by 26 of the 38 patients
Adverse effectn%
Vomiting1436.8
Abdominal pain1334.2
Metallic taste615.8
Diarrhea513.2
Nausea513.2
Dizziness25.3
Headache25.3
Asthenia12.6
Skin rash12.6
Table 3 Influence of clinical and histological variables on therapeutic success
Eradication rate (%)Odds ratio195% CIP
Demographic data
Female gender66.70.330.03-2.180.27
Age ≤ 10 yr66.70.560.1-3.110.47
Indication for treatment
Ulcer-like functional dyspepsia65.50.000.0-1.230.08
Initial endoscopy
Normal examination76.91.300.23-9.441
Nodular gastritis256.20.240.03-1.390.08
Duodenal ulcer or erosive bulbitis100undefinedundefined0.16
Histology
Intense activity70.00.700.13-5.971
Moderate activity78.91.730.32-10.170.46
Light activity66.70.670.10-5.280.68
Intense density75.01.090.15-13.191
Moderate density73.71.000.18-5.451
Light density72.70.930.16-7.011
Adverse effects
Yes76.91.670.27-9.370.69